TrialJournal of global oncology2019

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.

Seock-Ah Im et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.